Manufacturing Equipment, Biologics

Nov 06, 2018
By BioPharm International Editors
The company has rolled out the first batch of TRACON Pharmaceutical’s lead product candidate from its Singapore-based single-use bioreactor.
Nov 01, 2018
BioPharm International
Advanced therapy medicinal products pose unique manufacturing challenges that will require appropriate and thoughtful facility design and equipment.
Nov 01, 2018
BioPharm International
Recent equipment and updated product options offer improvement to a range of biopharmaceutical manufacturing tasks.
Oct 01, 2018
BioPharm International
The maturation of single-use technologies presents commercial bioprocessing options for small-volume drug products.
Oct 01, 2018
By BioPharm International Editors
The companies partnered to build a 500-L single-use pilot-scale plant for biologics production.
Sep 20, 2018
By BioPharm International Editors
The biopharmaceutical company will invest approximately $800 million to expand facilities and manufacturing capacity at its campus in Rensselaer County, NY.
Sep 20, 2018
By BioPharm International Editors
BeiGene is set to build late-stage clinical and commercial production capacity for cancer monoclonal antibodies with GE Healthcare’s KUBio, the prefabricated biopharma facility based on single-use technologies.
Sep 20, 2018
By BioPharm International Editors
The CHF 400-million (US$416-million) investment in Lonza's biopark in Visp, Switzerland, will expand Ibex Solutions with two new offerings, drug substance development and drug substance and drug product manufacturing.
Sep 13, 2018
By BioPharm International Editors
The new features on the purifier deliver additional sizes and sterilization/sanitization compatibility.
Sep 06, 2018
By BioPharm International Editors
The company is increasing manufacturing capacity at its Copenhagen, Denmark facility with the addition of six new bioreactors.
native1_300x100
lorem ipsum